Table 2 Mortality age standardised rates (ASRs) per 100 000 15–90+ year olds, deaths, total percentage changes, and average annual percentage changes (AAPC) for 1993, 2014 and 2035 by cancer site and sex

From: Cancer incidence and mortality projections in the UK until 2035

  1993 ASR 2014 ASR 2035 ASR ASR Percentage Change 2014–2035 ASR AAPC 2015–2035 1993 deaths 2014 deaths 2035 deaths Deaths Percentage Change 2014–2035 Deaths AAPC 2015–2035
Males
Cancer site           
 Anus 0.62 0.66 0.91 37.90 1.81 94 143 302.52 111.55 3.67
 Bladder 25.66 17.98 13.79 −23.31 −1.19 3593 3614 5189.82 43.60 1.78
 Bone 0.63 0.80 0.48 −40.29 −1.49 128 187 154.71 −17.27 −0.07
 Bowel 60.00 40.41 28.86 −28.58 −1.59 9155 8566 10270.28 19.90 0.87
 Brain 11.55 12.22 11.97 −2.10 −0.19 2125 2821 3887.01 37.79 1.43
 Hodgkin Lymphoma 1.18 0.91 0.75 −18.09 −0.39 235 211 250.45 18.70 1.35
 Kidney 10.65 12.75 11.40 −10.59 −0.47 1752 2771 3957.66 42.82 1.74
 Larynx 4.66 3.10 2.80 −9.77 −0.39 761 677 954.03 40.92 1.67
 Leukaemia 12.81 12.41 9.64 −22.35 −1.32 2041 2630 3551.68 35.04 1.32
 Liver 6.68 13.85 21.75 57.01 1.99 1106 3052 7449.34 144.08 4.03
 Lung 155.34 89.69 64.97 −27.56 −1.45 24 910 19 563 22226.74 13.62 0.69
 Malignant Melanoma 4.15 6.44 5.57 −13.38 −0.57 730 1431 1974.49 37.98 1.66
 Mesothelioma 5.94 9.93 5.10 −48.66 −3.54 1030.20 2153.58 1875.83 −12.90 −0.90
 Myeloma 7.85 7.50 6.33 −15.64 −0.69 1225 1596 2264.73 41.90 1.79
 Non-Hodgkin Lymphoma 13.37 12.10 9.49 −21.58 −1.20 2245 2603 3434.57 31.95 1.27
 Oesophagus 23.91 23.53 19.35 −17.79 −0.96 3876 5213 6570.96 26.05 1.09
 Oral 6.19 6.97 9.51 36.54 1.42 1035 1613 3074.45 90.60 2.97
 Pancreas 20.31 20.07 20.00 −0.36 −0.06 3208 4426 6871.66 55.26 2.06
 Prostate 71.61 57.22 47.86 −16.36 −0.74 9519 11 287 18336.23 62.45 2.38
 Stomach 33.48 13.69 9.31 −32.00 −1.80 5148 2919 3294.87 12.88 0.63
 Testis 0.59 0.24 0.15 −34.87 −2.24 118 60 51.13 −14.79 −0.79
 Thyroid 0.72 0.71 0.68 −4.63 −0.27 120 154 234.55 52.30 1.91
 Other 64.78 40.75 29.22 −28.30 −1.68 10 068 8641 10407.62 20.44 0.81
 All cancers 542.69 403.92 329.86 −18.33 −0.94 84222.20 86331.58 116585.30 35.04 1.45
Females
Cancer site           
 Anus 0.62 0.78 1.26 61.84 2.28 139 215 474.84 120.86 3.75
 Bladder 7.47 6.12 5.78 −5.56 −0.29 1763 1755 2581.42 47.09 1.87
 Bone 0.39 0.55 0.54 −2.67 0.79 96 152 197.29 29.80 2.15
 Bowel 38.91 25.97 21.08 −18.83 −0.99 9019 7337 8976.63 22.35 1.04
 Brain 8.08 8.47 8.26 −2.40 −0.21 1830 2295 3072.60 33.88 1.31
 Breast 64.89 41.15 30.51 −25.86 −1.42 14 612 11 360 11875.54 4.54 0.26
 Cervix 7.37 3.31 3.08 −6.90 −0.37 1681 890 1029.95 15.72 0.66
 Hodgkin Lymphoma 0.70 0.52 0.31 −39.82 −2.21 170 143 117.70 −17.69 −0.61
 Kidney 5.00 5.88 4.29 −27.07 −1.56 1145 1637 1781.37 8.82 0.44
 Larynx 0.93 0.61 0.74 21.97 0.77 211 162 274.68 69.56 2.25
 Leukaemia 7.66 6.82 5.78 −15.31 −1.02 1785 1907 2539.11 33.15 1.16
 Liver 3.64 7.38 11.33 53.40 1.79 838 2035 4730.14 132.44 3.76
 Lung 55.99 60.52 51.81 −14.38 −0.70 12 737 16 331 19604.32 20.04 0.92
 Malignant Melanoma 3.51 3.71 3.05 −17.98 −0.88 802 1027 1235.89 20.34 1.01
 Mesothelioma 0.67 1.59 1.01 −36.47 −2.41 149.62 423.87 422.05 −0.43 −0.21
 Myeloma 5.45 4.79 3.72 −22.24 −1.18 1259 1332 1570.42 17.90 0.88
 Non-Hodgkin Lymphoma 8.61 7.86 6.25 −20.49 −1.20 1998 2183 2694.18 23.42 0.96
 Oesophagus 11.06 9.25 7.64 −17.44 −0.78 2587 2577 3176.99 23.28 1.18
 Oral 2.37 2.82 4.00 41.82 1.53 535 773 1517.44 96.31 3.09
 Ovary 19.23 15.36 9.62 −37.42 −2.28 4288 4127 3743.83 −9.28 −0.48
 Pancreas 14.84 16.02 15.12 −5.63 −0.31 3428 4391 6132.70 39.67 1.58
 Stomach 14.17 5.92 4.53 −23.62 −1.32 3342 1657 1897.55 14.52 0.67
 Thyroid 1.06 0.79 0.93 17.21 0.52 248 222 377.76 70.16 2.35
 Uterus 6.35 7.98 9.47 18.66 0.73 1453 2166 3829.07 76.78 2.61
 Other 44.69 35.61 28.93 −18.76 −1.09 10 374 9992 12107.30 21.17 0.87
 All cancers 333.68 279.78 239.02 −14.57 −0.77 76489.62 77089.87 95960.78 24.48 1.06